Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.

Jang D S, Ye W, Guimei T, Solomon M, Southall N, Hu X, Marugan J, Ferrer M, Maegawa GHB

J Neurosci Res. 2016 Nov; 94(11):1231-45. PMID: 27638606. Abstract